| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,522 | 11,778 | 10,864 | 9,271 | | Cost of Revenue | 7,355 | 7,531 | 7,120 | 6,985 | | | Gross Profit | 5,167 | 4,247 | 3,744 | 2,286 | | | Operating Expenses | | Research Development | 209 | 217 | 303 | 394 | | Selling General and Administrative | 3,429 | 3,258 | 3,434 | 3,593 | | Non Recurring | (600) |
-
| 600 | 15,091 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,480 | 772 | (593) | (16,791) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (573) | 8 | 91 | 8 | | Earnings Before Interest And Taxes | 1,556 | 779 | (502) | (16,784) | | Interest Expense | 88 | 86 | 104 | 102 | | Income Before Tax | 1,468 | 694 | (606) | (16,886) | | Income Tax Expense | 28 | (3) |
-
| 25 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,440 | 697 | (606) | (16,911) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,440 | 697 | (606) | (16,911) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,440 | $697 | ($606) | ($16,911) |
|
0.02% Nasdaq 
0.33%
Income Statement
